Bleomycin
Term · Oncology and biomedicine · MLC-T-ONC-012057
A mixture of glycopeptide antineoplastic antibiotics isolated from the bacterium Streptomyces verticillus. Bleomycin forms complexes with iron that reduce molecular oxygen to superoxide and hydroxyl radicals which cause single- and double-stranded breaks in DNA; these reactive oxygen species also induce lipid peroxidation, carbohydrate oxidation, and alterations in prostaglandin synthesis and degradation.
| Identifier | MLC-T-ONC-012057 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | BLEO |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012057",
"term": "Bleomycin",
"field": "Oncology and biomedicine",
"definition": "A mixture of glycopeptide antineoplastic antibiotics isolated from the bacterium Streptomyces verticillus. Bleomycin forms complexes with iron that reduce molecular oxygen to superoxide and hydroxyl radicals which cause single- and double-stranded breaks in DNA; these reactive oxygen species also induce lipid peroxidation, carbohydrate oxidation, and alterations in prostaglandin synthesis and degradation.",
"abbreviation": "BLEO",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/bleomycin/"
}
Record 3,653 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.